EPKINLY Oncology Milestone: The Dawn of Next-Generation...

toegevoegd een audio Health

2025-06-09 06:19:00 - Translate

EPKINLY Oncology Milestone: The Dawn of Next-Generation Immunotherapy for Resistant DLBCL

The oncology community has witnessed a historic milestone with the regulatory approval of EPKINLY (epcoritamab), marking the first successful deployment of CD20xCD3 bispecific antibody technology in diffuse large B-cell lymphoma treatment. This achievement represents decades of scientific research culminating in a therapeutic breakthrough that fundamentally changes the...

0 Reacties 0 aandelen 4K Views 0 voorbeeld